Literature DB >> 20978558

Treatment of chronic hepatitis C in patients with Crohn's disease.

Jill Gaidos, Virginia Clark, John F Valentine.   

Abstract

Entities:  

Year:  2010        PMID： 20978558      PMCID： PMC2950671     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  13 in total

1.  Immunomodulatory drugs in Crohn's disease patients with hepatitis B or C virus infection.

Authors:  Livia Biancone; Giovanna Del Vecchio Blanco; Francesco Pallone; Fabiana Castiglione; Giampaolo Bresci; Giancarlo Sturniolo
Journal:  Gastroenterology       Date:  2002-02       Impact factor: 22.682

Review 2.  Impact of immunosuppressive therapy on recurrence of hepatitis C.

Authors:  Gregory T Everson
Journal:  Liver Transpl       Date:  2002-10       Impact factor: 5.799

3.  Concomitant therapy of Crohn's disease and hepatitis C with budesonide and antivirals.

Authors:  Alok Gupta; Michael D Sitrin
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-08

4.  Successful treatment of chronic hepatitis C with pegylated interferon, ribavirin, and infliximab in a patient with Crohn's disease.

Authors:  Manal F Abdelmalek; Chen Liu; John F Valentine
Journal:  Am J Gastroenterol       Date:  2007-06       Impact factor: 10.864

5.  Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study.

Authors:  Nizar N Zein
Journal:  J Hepatol       Date:  2005-03       Impact factor: 25.083

6.  Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C.

Authors:  Roberto J Firpi; Manal F Abdelmalek; Consuelo Soldevila-Pico; Alan Reed; Alan Hemming; Richard Howard; William Van Der Werf; Gregory Lauwers; Chen Liu; James M Crawford; Gary L Davis; David R Nelson
Journal:  Liver Transpl       Date:  2002-11       Impact factor: 5.799

Review 7.  Treatment of hepatitis C.

Authors:  J Heathcote; J Main
Journal:  J Viral Hepat       Date:  2005-05       Impact factor: 3.728

8.  Safety of anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis and chronic hepatitis C virus infection.

Authors:  Clodoveo Ferri; Gianfranco Ferraccioli; Daniela Ferrari; Mauro Galeazzi; Giovanni Lapadula; Carlomaurizio Montecucco; Giovanni Triolo; Gabriele Valentini; Guido Valesini
Journal:  J Rheumatol       Date:  2008-08-01       Impact factor: 4.666

Review 9.  NIH Consensus Statement on Management of Hepatitis C: 2002.

Authors: 
Journal:  NIH Consens State Sci Statements       Date:  2002 Jun 10-12

Review 10.  Budesonide for maintenance of remission in Crohn's disease.

Authors:  Eric I Benchimol; Cynthia H Seow; Anthony R Otley; A Hillary Steinhart
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.